 |
March 11, 2013
CGPA: Alberta Government’s Price Cuts to Cost-Saving Generic Prescription Medicines Short-sighted and Misdirected
|
|
The following is a statement by Jim Keon, President of the Canadian Generic Pharmaceutical Association (CGPA), regarding the Alberta government’s announced plans for further cuts to generic prescription drug prices.
| read more... |
|
January 18, 2013
CGPA Response to Provincial Governments Announcement
Regarding Generic Prescription Drug Prices
|
|
Jim Keon, President of the Canadian Generic Pharmaceutical Association (CGPA), today made the following statement regarding today's announcement by provincial governments on generic drug pricing
| read more... |
|
November 20, 2012
QUEBEC BUDGET ANNOUNCES ELIMINATION OF "15-YEAR RULE"
|
|
The Canadian Generic Pharmaceutical Association (CGPA) today welcomed the announcement that the Government of Quebec will eliminate the Province’s "15-year rule". The measure was included in Quebec’s 2013 Budget.
| read more... |
|
October 24, 2012
NEW STUDY CAUTIONS PROVINCES ABOUT TENDERING FOR GENERIC MEDICINES |
|
Tendering for generic prescription medicines, as announced by Canada’s Premiers in July 2012, could result in drug shortages and delayed savings to Canada’s health-care system, according to a new study by two of Canada’s top academics on pharmaceutical policy. | read more... |
|
October 12, 2012
Joint Statement on the Negotiations for a
Comprehensive Economic and Trade Agreement (CETA)
Between Canada and the European Union
|
|
The following is a joint statement by Greg Perry, Director General of the European Generic medicines Association (EGA) and Jim Keon, President of the Canadian Generic Pharmaceutical Association (CGPA) on the negotiations for a Comprehensive Economic and Trade Agreement (CETA) between the European Union and Canada
| read more... |
|
October 9, 2012
GENERIC PHARMACEUTICAL INDUSTRY WELCOMES
CANADA’S ADMISSION TO TRANS-PACIFIC PARTNERSHIP NEGOTIATIONS
|
|
Jim Keon, President of the Canadian Generic Pharmaceutical Association (CGPA), today made the following statement regarding Canada’s admission to the Trans-Pacific Partnership (TPP) negotiations | read more... |
|
October 5, 2012
INTERNATIONAL TRADE MINISTER ED FAST
OFFICIALLY OPENS APOTEX OFFICES IN SAUDI ARABIA
|
|
The Honourable Ed Fast, Minister of International Trade and Minister for the Asia-Pacific Gateway, announced the opening of three new Apotex scientific offices today during a trade mission to Saudi Arabia and Jordan. | read more... |
|
September 17, 2012
Generic Pharmaceutical Industry Reaffirms Support
for Government of Canada’s Trade Agenda
|
|
The following is a statement by Jim Keon, President of the Canadian Generic Pharmaceutical Association (CGPA), regarding the latest round of negotiations for a Comprehensive Economic and Trade Agreement (CETA) between Canada and the European Union (EU), which begin in Ottawa today | read more... |
|
July 27, 2012
CGPA Statement on the Release of the Report of the Council of the Federation
Working Group on Health Care Innovation
|
|
The following is a statement by Jim Keon, President of the Canadian Generic Pharmaceutical Association (CGPA), regarding the release of the report by the Council of the Federation Working Group on Health Care Innovation, From Innovation to Action. | read more... |
|
June 27, 2012
New Data Shows Brand-Name Drug Companies Breaking R&D Commitment to Canadians
Canada Must Reject EU’s Demands For Longer Market Monopolies
|
|
New data on research and development spending in Canada by brand-name drug companies provides further proof that there is no link between longer market monopolies and increased investments. Demands for even longer monopolies in Canada must be rejected, Jim Keon, President of the Canadian Generic Pharmaceutical Association (CGPA) said today. | read more... |
|
June 19, 2012
Statement from the Canadian Generic Pharmaceutical Association
Regarding Invitation for Canada to Join the Trans-Pacific Partnership (TPP) Negotiations
|
|
The following is a statement by Jim Keon, President of the Canadian Generic Pharmaceutical Association (CGPA), regarding the formal invitation received by Canada to join the Trans-Pacific Partnership (TPP) negotiations.
| read more... |
|
June 15, 2012
Statement from the Canadian Generic Pharmaceutical Association
Regarding Windsor-Detroit Border Announcement
|
|
The following is a statement by Jim Keon, President of the Canadian Generic Pharmaceutical Association (CGPA), regarding construction of a second bridge at the Windsor-Detroit border.
| read more... |
|
June 7, 2012
Release of Canadian Prescription Drug Sales Information
Shows Generic Medicines Provide Best Value Ever
|
|
The release of 2011 Canadian prescription drug sales information by IMS Brogan shows that generic prescription medicines offer greater value than ever before for Canadians, Jim Keon, President of the Canadian Generic Pharmaceutical Association (CGPA), said today.
| read more... |
|
April 27, 2012
Generic Pharmaceutical Industry Supports Government of Canada's Goal of Concluding Trade Agreement with European Union that is in the Best Interest of Canadians |
|
The following is a statement by Jim Keon, President of the Canadian Generic Pharmaceutical Association (CGPA), regarding the current negotiations for a Comprehensive Economic and Trade Agreement (CETA) between Canada and the European Union (EU):
| read more... |
|
April 21, 2012
Statement from the Canadian Generic Pharmaceutical Association (CGPA) Regarding the Ontario Government's Plan to Cut Low-Cost Generic Drugs |
|
The following is a statement by Jim Keon, President of the Canadian Generic Pharmaceutical Association (CGPA), regarding the Ontario government’s announced plans for further cuts to generic prescription drug prices
| read more... |
|
March 16, 2012
Statement from Canada’s Pharmaceutical Industry Regarding
House of Commons Motion on National Drug Strategy |
|
Canada’s pharmaceutical industry looks forward to working with the federal government, provincial and territorial governments, and our partners in the health-care sector to develop a nationwide strategy to anticipate, identify and manage shortages of prescription medications.| read more... |
|
March 12, 2012
Canada's Pharmaceutical Industry
Comes Together To Address Drug Shortages |
|
Canada's Research-Based Pharmaceutical Companies (Rx&D) and the Canadian Generic Pharmaceutical Association (CGPA) today announced their commitment and financial support in responding urgently to prescription drug shortages.| read more... |
|
March 9, 2012
Statement from the Canadian Generic Pharmaceutical Association (CGPA) Regarding Shortages of Prescription Medicines in Canada |
|
"Canada’s generic pharmaceutical manufacturers continue to aggressively pursue all available options to prevent shortages of prescription medicines in Canada, particularly drug products identified as medically necessary. | read more... |
|
March 8, 2012
Statement from the Canadian Generic Pharmaceutical Association (CGPA) Regarding Shortages of Prescription Medicines in Canada |
|
"Millions of Canadians rely on generic prescription medicines daily for their pharmaceutical treatments and Canada’s generic pharmaceutical manufacturers take the responsibility of providing high-quality, lower-cost generic pharmaceutical products for Canadian patients extremely seriously. | read more... |
|
January 9, 2012
GENERIC PRESCRIPTION MEDICINES SAVED CANADA'S HEALTH-CARE SYSTEM
$26-BILLION OVER PAST FIVE YEARS
|
|
The use of generic prescription medicines has saved Canada’s health-care system nearly $26-billion since 2007, according to an analysis of Canadian retail prescription drug sales information released today by the Canadian Generic Pharmaceutical Association (CGPA). | read more... |
|
| |
|
TOP |
| |
|
|
